Back
NovoCure Vs. Perspective Therapeutics Industry Stock Comparison
Buy
58
NVCR
NovoCure
Last Price:
22.01
Seasonality Move:
12.1%
Buy
52
CATX
Perspective Therapeutics
Last Price:
1.60
Seasonality Move:
2.9%
Buy
58
NovoCure (NVCR)
is a Buy
Is NovoCure a Buy, Sell or Hold?
- The current NovoCure [NVCR] share price is $21.99. The Score for NVCR is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- NVCR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
52
Perspective Therapeutics (CATX)
is a Buy
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $1.60. The Score for CATX is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- CATX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NVCR Stock Price Chart
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $1.60
The current trend is moderately bearish and CATX is experiencing slight buying pressure.
NVCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2 | Buy |
| Relative Strength Index (14 RSI): | 84.57 | Buy |
| Chaikin Money Flow: | 280430 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.59 - 18.21) | Buy |
| Bollinger Bands (100): | (12.84 - 16.62) | Buy |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 49.16 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.53 - 1.77) | Sell |
| Bollinger Bands (100): | (0.67 - 1.53) | Buy |
NVCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.02 | Buy |
| 20-day SMA: | 15.55 | Buy |
| 50-day SMA: | 14.64 | Buy |
| 200-day SMA: | 16.14 | Buy |
| 8-day EMA: | 19.48 | Buy |
| 20-day EMA: | 16.9 | Buy |
| 50-day EMA: | 15.36 | Buy |
| 200-day EMA: | 21.82 | Buy |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.69 | Sell |
| 20-day SMA: | 1.69 | Sell |
| 50-day SMA: | 1.47 | Buy |
| 200-day SMA: | 0.71 | Buy |
| 8-day EMA: | 1.66 | Sell |
| 20-day EMA: | 1.65 | Sell |
| 50-day EMA: | 1.46 | Buy |
| 200-day EMA: | 0.91 | Buy |
NovoCure Earnings Growth & NVCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.43 per share, and a decrease next year of $0.16 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
NovoCure Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||